Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SOFTSWISS and Evolution Launch Evo Prime Drop Campaign

The SOFTSWISS Jackpot Aggregator, a multipurpose gamification system for managing promotional campaigns, launched the Evo Prime Drop campaign in partnership with Evolution Gaming Group AB in March. The Evo Prime Drop aims to enhance player engagement and highlight captivating games integrated with Evolution.Evolution is a leading B2B solution provider for casino operators offering live casino, live game shows, slots and more. The Evo Prime Drop leverages Evolution's extensive portfolio, available through the SOFTSWISS Game Aggregator, to feature premium games from such developers as NetEnt,

Invitation to media and analyst briefing for Ericsson Q1 2024 report

· Report to be released at approximately 7:00 AM CEST on April 16, 2024 · One live video webcast for analysts, investors, and journalists at 9:00 AM CESTEricsson's (NASDAQ: ERIC) financial report for the first quarter 2024 will be published at approximately 7:00 AM CEST on April 16, 2024. The company will issue a press release with the complete financial report attached, including tables, in PDF format. Following publication of the press release, the financial report will be available on Ericsson's website: www.ericsson.com/en/investors/financial-reports/interim-reports President and

Comments concerning SSAB's decision to invest in Luleå

SSAB today announced its decision to proceed with plans to build a new electric arc furnace and minimill in Luleå.“The decision by our partner in Hybrit and largest customer, SSAB, to invest in Luleå bodes well for our planned transition to production of fossil-free sponge iron in Gällivare. This increases the level of assurance with respect to LKAB's future investment decision for the Hybrit demonstration plant, which is the first step in the successive transition we are planning,” says Jan Moström, LKAB's President and CEO. LKAB's and SSAB's operations have long been integrated and the

Repurchases of shares during week 13, 2024

Between 25 March 2024 and 28 March 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 110,150 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.Between 25 March 2024 and 28 March 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 110,150 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced

Eficode appoints Hans Parvikoski as Chief Financial Officer

Helsinki, Finland, 2 April 2024 -  Hans Parvikoski has been appointed Chief Financial Officer at Eficode. In his new role, he is also a member of the Group Management Team. Hans Parvikoski has a broad finance background in IT services companies, both private-equity-owned and stock-listed. His extensive career as a CFO, spanning over 15 years, has primarily been focused on the IT and technology services sector.“Over the previous five years, Eficode has evolved from a Finnish DevOps pioneer to a leading European company in Atlassian, GitHub, and GitLab technologies and Agile, DevOps, and

Read original

BerGenBio ASA: Commencement of the last exercise period for warrants issued in connection with rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Bergen, Norway, 2 April 2024 – Reference is made to the stock exchange announcement from BerGenBio ASA (the "Company") dated 14 June 2023 regarding the final results of the rights issue of 2,500,000,000 new shares in the

BioStock: WntResearch’s new CEO comments on his first month in the position

Development company WntResearch recently recruited the first patient for the expansion part of the ongoing phase II study, NeoFox. This coincided with Per Norlén’s first days at the helm of the company. BioStock contacted him to find out how he sees the potential of Foxy-5, and how he, with a long career as CEO of several biotech companies, wants to contribute to advancing the positions of the project.Read the full article at biostock.se : https://www.biostock.se/en/2024/03/wntresearchs-new-ceo-comments-on-his-first-month-in-the-position/ This is a press

Wyld Networks receive first satellite IoT data from Australia

Wyld Networks in conjunction with Queensland based PLF Australia have begun monitoring soil moisture utilising Low Earth Orbiting satellite connectivity.Satellite IoT in Australia utilising low power connectivity is essential for optimising land management. This process plays a crucial role in optimising irrigation, maximising yields and improving biodiversity. Wyld have installed Wyld Connect AT430 terminals and AT302 modems with soil moisture sensors from DFM Technologies in Australia to monitor soil moisture and are now collecting data. Vast areas of agricultural land in Australia

Teleste: Managers´ transactions – Harju, Esa

Teleste CorporationManagers´ transactionsApril 2, 2024, at 9:45 a.m. EEST   TELESTE: MANAGERS´ TRANSACTIONS – HARJU, ESA Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Esa Harju Position: Chief Executive Officer  Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 57178/5/4 ____________________________________________ Transaction date: 2024-03-28 Outside a trading venue Instrument type: SHARE ISIN:

Repurchase of Truecaller B shares in week 13, 2024

During 25 March 2024 and 28 March 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 136,717 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024 AGM which will be held in May 2024, and is carried out in accordance “Emittentregelverket”. On the Annual General Meeting 2023 the Board was authorized to buy back B-shares up until the

Teleste: Managers´ transactions – Hyytiäinen, Juha

Teleste CorporationManagers´ transactionsApril 2, 2024, at 9:45 a.m. EEST TELESTE: MANAGERS´ TRANSACTIONS – HYYTIÄINEN, JUHA Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Juha Hyytiäinen Position: Chief Financial Officer  Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 57184/5/4 ____________________________________________ Transaction date: 2024-03-28 Outside a trading venue Instrument type: SHARE

Teleste: Managers´ transactions – Narjus, Hanno

Teleste CorporationManagers´ transactionsApril 2, 2024, at 9:45 a.m. EEST TELESTE: MANAGERS´ TRANSACTIONS – NARJUS, HANNO Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hanno Narjus Position: Other senior manager  Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 57185/5/4 ____________________________________________ Transaction date: 2024-03-28 Outside a trading venue Instrument type: SHARE ISIN:

Closing of the strategic combination of Assemblin and Caverion and composition of the Board of Directors

2 April 2024 at 8:30 CET On April 1, Triton completed all legal and administrative proceedings needed to create Assemblin Caverion Group and, subsequently, successfully closed the combination between the previous portfolio companies Assemblin and Caverion. The Parent Company of the new, combined group is Assemblin Group AB (under name change to Assemblin Caverion Group AB), Corp. ID No. 559427-2006, domiciled in Stockholm, Sweden. In connection with the regular Annual General Meeting of Assemblin Group AB on March 27, 2024, Susanne Ekblom and Per Ingemar Persson’s term as Board

As part of CLS expansion in Europe prostate cancer patients have been treated with CLS TRANBERG Thermal Therapy System for the first time in Italy

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announced that two patients with localized prostate cancer have been safely treated with the TRANBERG® Thermal Therapy System at the San Luigi Gonzaga University Hospital in Turin, Italy. These are the first patient cases in Italy, and part of CLS commercialization and expansion in Europe.The urology department of the hospital, headed by Professor Francesco Porpiglia, has extensive experience in using US-fusion for targeted prostate biopsies and performs approximately 450 prostatectomies and more than 50

The strategic combination of Caverion and Assemblin is completed

Caverion Corporation Investor News 2 April 2024 at 9:30 EETTriton Investment Advisers LLP, the company managing the entities comprising Triton Fund V (together “Triton”), which indirectly control Crayfish BidCo Oy, completed on 1 April 2024 all legal and administrative proceedings needed to create Assemblin Caverion Group and subsequently successfully closed the combination between the previous portfolio companies Assemblin Group AB (“Assemblin”) and Caverion Corporation (“Caverion”). Crayfish BidCo Oy holds approximately 94.39% of all outstanding shares and votes in Caverion (excluding

Invitation to Epiroc’s results presentation for Q1 2024 on April 23

Stockholm, Sweden: Epiroc AB, a leading productivity and sustainability partner for the mining and construction industries, will publish its Q1 2024 results on Tuesday April 23 at approximately 08.00 CEST. A results presentation for investors, analysts and media will be held at 10.00 CEST.The report will be presented by President and CEO Helena Hedblom and CFO Håkan Folin. It will be held in English and begin with a short presentation of the report followed by a question-and-answer session. To follow the presentation webcast, either access the link here 

Closing of the strategic combination of Assemblin and Caverion and changes in the Board of Directors

On April 1, Triton completed all legal and administrative proceedings needed to create Assemblin Caverion Group and, subsequently, successfully closed the combination between the previous portfolio companies Assemblin and Caverion.The Parent Company of the new, combined group is Assemblin Group AB (under name change to Assemblin Caverion Group AB), Corp. ID No. 559427-2006, domiciled in Stockholm, Sweden. In connection with the regular Annual General Meeting of Assemblin Group AB on March 27, 2024, Susanne Ekblom and Per Ingemar Persson’s term as Board members ended and Mikael Aro (

Viaplay Group and Talpa Network enter linear TV partnership in the Netherlands

· Talpa Network’s SBS9 channel to rebrand as Viaplay TV from 5 April · Channel to show selected content from Viaplay’s premium sports portfolio · Viaplay TV available through all major Dutch TV distributors Viaplay Group and Dutch media company Talpa Network have agreed a linear TV partnership in the Netherlands. Starting 5 April, Talpa Network’s widely available SBS9 linear TV channel will be rebranded as Viaplay TV, and will show selected content from the Viaplay streaming service’s portfolio of premium sports. Viaplay TV’s first live broadcast will be the second free practice

BioStock: Alligator Bioscience on the importance of prolonging life

What does time mean to a person who's cancer might not be cured? Prolonged life can bring hope for alternative treatments, or simply allow more time with loved ones. Alligator Bioscience aim to help patients with pancreatic cancer, through activating the body's own immune system. As the FDA has endorsed a phase III study with the company's lead candidate, BioStock studio asked CEO Søren Bregenholt to expand on the next step and his personal engagement in helping cancerpatients.Watch the interview with CEO Søren Bregenholt at biostock.se : https://www.biostock.

ArcticZymes Technologies ASA - resignation of board member

Tromsø, Norway, 2nd April 2024 - Board member Edgar Koster has informed the board that he will resign from the board with immediate effect for personal reasons.The remaining board complies with the requirements regarding board composition and will still constitute a quorum. Dr Marie Roskrow,  Chairman of the Board,  commented, "on behalf of my colleagues and myself,  I would like thank Edgar very much for his contribution to the Company over the past year and we wish him well for the future." For more information, please contact:Chairman of the BoardDr. Marie Roskrow+44 (0)7496

Voydeya approved in US

2 April 2024 Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with the rare disease PNH Approval of first-in-class, oral, Factor D inhibitor based on results from pivotal ALPHA Phase III trial Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular haemolysis (EVH) in adults with paroxysmal nocturnal haemoglobinuria (PNH).[1] Voydeya is a first-in-class, oral, Factor D inhibitor developed as an add-on to standard-of-care Ultomiris (

AFRY is the trusted partner for TNB Renewables in a new solar power project in Malaysia

TNB Renewables Sdn Bhd has appointed AFRY as the owner’s engineer for the construction of a large-scale solar photovoltaic plant in Kedah, Malaysia, that will provide clean energy to a corporate consumer through a long-term agreement.TNB Renewables Sdn Bhd (TRe) is a fully owned subsidiary of Malaysia’s leading electricity utility company, Tenaga Nasional Berhad (TNB), that has a firm commitment to accelerating the transition to sustainable energy in the country and across Southeast Asia. TRe has chosen AFRY to provide owner’s engineering services on the Corporate Green Power Programme (

FDA accepts Dato-DXd BLA for breast cancer

2 April 2024 Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer Application based on results from the TROPION-Breast01 Phase III trial Additional BLA under review in the US for AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan for patients with advanced nonsquamous non-small cell lung cancer AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with

There are no items matching the current filter
There are no more items matching the current filter
Back to top